First, B. longum 420 significantly augmented the anti-tumor activity in mice loaded with Renca, mouse RCC tumors treated with an anti-PD-1 antibody, and mice treated with anti-PD-1 and anti-CTLA-4 antibodies. The gene discussed is CTLA4; the disease is renal cell carcinoma.